z-logo
open-access-imgOpen Access
Antinociceptive and anti‐inflammatory effects of the essential oil from Eremanthus erythropappus leaves
Author(s) -
Sousa Orlando V.,
Silvério Marcelo S.,
DelVechioVieira Glauciemar,
Matheus Filipe C.,
Yamamoto Célia H.,
Alves Maria S.
Publication year - 2008
Publication title -
journal of pharmacy and pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.745
H-Index - 118
eISSN - 2042-7158
pISSN - 0022-3573
DOI - 10.1211/jpp.60.6.0013
Subject(s) - licking , carrageenan , chemistry , essential oil , traditional medicine , analgesic , nociception , pharmacology , ed50 , myrcene , medicine , food science , biochemistry , limonene , in vitro , receptor
The chemical composition of the essential oil from air‐dried leaves of Eremanthus erythropappus was studied. The main compounds were β‐pinene (23.24%), β‐caryophyllene (22.92%), β‐myrcene (10.03%) and germacrene D (9.40%). The essential oil had an LD50 of 2.90 gkg −1 in mice. Doses of 200 and 400 mgkg −1 inhibited 10.69% and 27.06% of acetic‐acid‐induced writhing in mice, respectively. In the formalin‐induced nociception test in mice, the essential oil inhibited the first phase of paw licking by 29.13% (400 mgkg −1 ) and the second phase by 32.74% (200 mgkg −1 ) and 37.55% (400 mgkg −1 ). In the hot‐plate test in mice, doses of 200 mgkg −1 and 400 mgkg −1 significantly increased the reaction time after 30, 60 and 90 min of treatment. Doses of 200 and 400 mgkg −1 inhibited carrageenan‐induced paw oedema in rats by 15.18% and 36.61%, respectively. Doses of 200 and 400 mgkg −1 administered 4 h before intra‐pleural injection of carrageenan significantly reduced exudate volume (by 20.20% and 48.70%, respectively) and leucocyte mobilization (by 5.88% and 17.29%, respectively). These results demonstrate that E. erythropappus has analgesic and anti‐inflammatory properties, supporting the use of this plant in folk medicine.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here